-
Male, C, Lensing, AWA, Palumbo, JS, Kumar, R, Nurmeev, I, Hege, K, Bonnet, D, Connor, P, Hooimeijer, HL, Torres, M, et al.
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial..
Lancet Haematol
7(1)
:
e18 -e27
2020
view publication
-
Young, G, Lensing, AW, Monagle, P, Male, C, Kubitza, D.
Rivaroxaban for Treatment of Pediatric Venous Thromboembolism. an Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation.
Blood
134(Supplement_1)
:
164
2019
view publication
-
Payne, RM, Burns, KM, Glatz, AC, Li, D, Li, X, Monagle, P, Newburger, JW, Swan, EA, Wheaton, O, Male, C, et al.
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study..
Am Heart J
217:
52 -63
2019
view publication
-
Hoq, M, Matthews, S, Karlaftis, V, Burgess, J, Cowley, J, Donath, S, Carlin, J, Yen, T, Ignjatovic, V, Monagle, P, et al.
Reference Values for 30 Common Biochemistry Analytes Across 5 Different Analyzers in Neonates and Children 30 Days to 18 Years of Age..
Clin Chem
65(10)
:
1317 -1326
2019
view publication
-
Monagle, P, Lensing, AWA, Thelen, K, Martinelli, I, Male, C, Santamaría, A, Samochatova, E, Kumar, R, Holzhauer, S, Saracco, P, et al.
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies..
Lancet Haematol
6(10)
:
e500 -e509
2019
view publication